Harada, Noboru <br/><br/>
Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation.  [electronic resource] 

 -  Anticancer research  Sep 2018 
 - 5513-5520 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Standard No.: </label>10.21873/anticanres.12885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Carbamates<br/>Drug Interactions<br/>Drug Monitoring<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--blood<br/>Humans<br/>Imidazoles--administration & dosage<br/>Immunosuppressive Agents--adverse effects<br/>Isoquinolines--administration & dosage<br/>Liver Transplantation--adverse effects<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Pyrrolidines<br/>Recurrence<br/>Sulfonamides--administration & dosage<br/>Tacrolimus--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Valine--analogs & derivatives<br/>Viral Load